サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1272772

歯周病治療薬の世界市場-2023-2030

Global Periodontal Therapeutics Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
歯周病治療薬の世界市場-2023-2030
出版日: 2023年05月15日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

歯周病治療薬の世界市場は、2022年に7億3,480万米ドルに達し、2030年には最大614億5,930万米ドルに達することで有利な成長が予測されます。歯周病治療薬市場は、予測期間中（2023-2030年）に9.2%のCAGRを示すと予測されています。抗生物質の使用に続くアジュバント療法が、この市場のトレンドを支えるでしょう。

歯周病の非外科的治療法には、抗菌製品の使用と口腔内の深い清掃が含まれ、歯周病を初期段階で回復させるのに十分であることが証明されています。歯周組織の炎症とプラークをコントロールするために、局所用と経口用の両方を含む抗生物質が処方されます。経口抗生物質は、微生物感染によって歯肉と歯の間にできた隙間（一般に歯周ポケットと呼ばれる）に置かれます。

歯周病は軽度から重度まであり、放置すると歯を失うこともあります。世界の歯周病治療薬市場の主な成長要因は、口腔衛生の重要性に対する意識の高まり、人口の高齢化、新製品・新技術の開発です。

市場力学

より良い口腔衛生に対する需要の高まりが、予測期間中の歯周病治療薬の世界市場成長を促進する

口腔衛生は、健康を維持するための最も重要なパラメータの1つになっています。そのため、口腔衛生に関する意識の高まりが、特に先進国における歯周病治療薬市場を牽引しています。世界保健機関（WHO）は、5億3,000万人以上の子どもたちが乳歯のう蝕に苦しんでいると述べています。

Procter &Gamble社やColgate-Palmolive社などの主要企業は、子供と大人の両方に歯科衛生に関する意識を広めるための取り組みを行い、歯周病治療薬の需要を創出しています。口腔衛生に対する意識の高まりにより、世界の歯周病治療薬市場は予測期間中に急速なペースで拡大すると考えられます。

抗生物質の臨床的非効率性が歯周病治療薬市場の成長を阻害します

歯周病の治療における抗生物質の部分的な非効率性は、歯周病治療薬市場の成長を制限する重要な要因となっています。歯周病の治療における抗生物質の使用は、特に重度の歯周炎の後期において、細菌感染の治療とポケットの治癒の効率が低いため、制限されています。

抗生物質による治療は、主に口腔外科手術や歯のクリーニング処置と組み合わせて使用されます。さらに、疾患治療における抗生物質の過剰使用や誤用は、抗菌剤耐性をもたらす可能性があります。これらの要因は、予測期間中、歯周病治療薬市場の成長を妨げると予想されます。

COVID-19の影響分析

世界の歯周病治療薬市場は、COVID-19の発生により低迷しています。2020年上半期には、歯周病治療に使用される抗生物質の売上高の伸びがわずかに減少しています。これは、歯科診療のための病院受診が減少し、世界中の歯科医からの処方箋が減少したことに起因していると考えられます。

ロシア・ウクライナ紛争の分析

世界の歯周病治療市場は、ロシアとウクライナの間で進行中の紛争によって間接的に影響を受ける可能性があります。紛争により複数の国からロシアに課されている経済制裁は、ロシア経済への波及につながっています。その結果、歯周病治療市場を含む歯科ヘルスケア産業が影響を受ける可能性があります。

ロシアでは歯科医療機器の輸出入が行われているため、戦争の影響によりロシアから他国への歯科医療機器の供給が妨げられる可能性があります。さらに、ファイザー、バイエル、サノフィなどの大手製薬会社は、ロシアにおける新規投資や開発を延期しており、医薬品のサプライチェーンに混乱が生じました。紛争によるこれらの混乱は、世界の歯周病治療薬市場に悪影響を及ぼしています。

本レポートの詳細について- サンプルを請求する

目次

第1章 調査手法と範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 治療法別スニペット
  • 疾患タイプ別スニペット
  • 販売チャネル別
  • 地域別スニペット

第4章 市場力学

  • 影響要因
    • 促進要因
      • より良い口腔衛生に対する需要の高まりが、予測期間中の歯周病治療薬の世界市場の成長を促進
    • 抑制要因
      • 抗生物質の臨床的非効率性が歯周病治療薬市場の成長を阻害
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 法規制の分析

第6章 COVID-19の分析

  • COVID-19の分析
    • COVID-19登場前シナリオ
    • 現在のCOVID-19シナリオ
    • COVID-19後または将来のシナリオ
  • COVID-19の中での価格・ダイナミクス
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • サマリー

第7章 治療法別

  • 全身性抗生物質
  • 局所抗生物質

第8章 疾患タイプ別

  • 歯肉炎
  • 慢性歯周炎
  • 進行性歯周炎
  • 壊死性歯周病
  • その他

第9章 流通チャネル別

  • 小売薬局・ドラッグストア
  • 病院薬局
  • デンタルクリニック
  • eコマース

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第12章 企業プロファイル

  • Kaken Pharmaceutical Co. Ltd.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展状況
  • Bausch Health
  • Colgate-Palmolive
  • Medicom
  • Pfizer Inc.
  • 3M
  • Den-Mat Holdings, LLC
  • Dentsply Sirona
  • Xttrium Laboratories, Inc.
  • Dexcel Pharma

第13章 付録

目次
Product Code: PH1888

Market Overview

The global periodontal therapeutics market reached US$ 734.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 61,459.3 million by 2030. The periodontal therapeutics market is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030). Adjuvant therapies following the use of antibiotics will support the trend in this market.

The non-surgical treatment procedures for gum disease include the use of antibacterial products and deep cleaning of the mouth which is proven to be sufficient for reversing the periodontal disease in its early stages. Antibiotics including both topical and oral are prescribed for the control of inflammation and plaque of the gum tissue. Oral antibiotics are placed in the gaps formed between gums and teeth by microbial infection, commonly called periodontal pockets.

Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies.

Market Dynamics

The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period

Oral hygiene has become one of the most important parameters for staying healthy. Therefore, the growing awareness about oral hygiene is driving the periodontal therapeutics market, specifically in developed countries. The World Health Organization (WHO) states that over 530 million children suffer from dental caries of primary teeth.

Key players such as Procter & Gamble and Colgate-Palmolive Company have undertaken initiatives to spread awareness regarding dental hygiene, both for children and adults, creating demand for periodontal therapeutic drugs. Owing to rising awareness for better oral hygiene, the global periodontal therapeutics market will upscale at a rapid pace over the forecast period.

The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth.

The partial inefficiency of antibiotics in the treatment of periodontal disease is a key factor limiting the growth of the periodontal therapeutics market. The use of antibiotics in the treatment of gum disease is limited, especially in the later stages of severe periodontitis owing to the low efficiency of treating bacterial infection and healing pockets.

Antibiotic treatment is mostly used in combination with oral surgery or dental cleaning procedures. Furthermore, the overuse and misuse of antibiotics in disease treatment may result in antimicrobial resistance. These factors are expected to hamper the periodontal therapeutics market growth over the forecast period.

COVID-19 Impact Analysis

The global periodontal therapeutics market has experienced a downturn due to the outbreak of COVID-19. In the first half of 2020, there was a slight decrease in the sales growth of antibiotics used for the treatment of periodontal disease. This can be attributed to a reduction in hospital visits for dental services and a decrease in prescriptions from dentists around the world.

Russia Ukraine Conflict Analysis

The global periodontal therapeutic market may be indirectly affected by the ongoing conflict between Russia and Ukraine. Economic sanctions imposed on Russia by several countries due to the conflict have led to repercussions in the Russian economy. As a result, the dental healthcare industry, including the periodontal therapeutic market, may be impacted.

The supply of dental equipment from Russia to other countries may be disrupted due to the war, as Russia both imports and exports dental equipment. Additionally, major pharmaceutical companies such as Pfizer, Bayer, and Sanofi have deferred new investments or developments in Russia, which has led to disruptions in the medicine supply chain. These disruptions caused by the conflict have had a negative impact on the global periodontal therapeutics market.

For more details on this report - Request For Sample

Segment Analysis

The global periodontal therapeutics market is segmented based on treatment, disease type, distribution channel, and region.

Gingivitis segment to hold the highest global periodontal therapeutics market share

The gingivitis segment is expected to dominate and account for 54.7% of the global periodontal therapeutics market share over the forecast period. Gingivitis is one of the most common types of periodontitis. This is usually caused by poor oral hygiene and red, swollen gums. They also tend to bleed easily.

The treatment of gingivitis focuses on reducing inflammation, removing plaque, and establishing good oral hygiene habits to prevent plaque build-up. Mouthwash, topical antibiotics, or antiseptics may be recommended. For more serious infections or periodontitis, the dentist may recommend oral antibiotics. For instance, over-the-counter medicated toothpaste, mouth rinses, and mouth sprays are very safe, provided they are used as directed. Therefore, this segment growth will boost the global periodontal therapeutics market growth over the forecast period.

Geographical Analysis

The presence of major players to dominate the North America region.

North America is expected to have a dominant global periodontal therapeutics market share of around 1/3rd of this market. The U.S. is the largest revenue contributor in North America, and the presence of a large dental workforce in this region indicates its dominance in the global market. For instance, according to the American Dental Association, as of 2022, there are 202,536 professionally active dentists in the U.S. There are 60.8 dentists per 100,000 U.S. population.

Competitive Landscape

The major global players in the market include Kaken Pharmaceutical Co. Ltd., Bausch Health, Colgate-Palmolive, Medicom, Pfizer Inc., 3M, Den-Mat Holdings, LLC, Dentsply Sirona, Xttrium Laboratories, Inc., and Dexcel Pharma.

Why Purchase the Report?

  • To visualize the global periodontal therapeutics- market segmentation based on treatment, disease type, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global periodontal therapeutics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global periodontal therapeutics market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Treatment
  • 3.2. Snippet by Disease Type
  • 3.3. Snippet by Distribution Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period
    • 4.1.2. Restraints
      • 4.1.2.1. The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Treatment

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.1.2. Market Attractiveness Index, By Treatment
  • 7.2. Systemic Antibiotics
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Local Antibiotics

8. By Disease Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 8.1.2. Market Attractiveness Index, By Disease Type
  • 8.2. Gingivitis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Chronic Periodontitis
  • 8.4. Aggressive Periodontitis
  • 8.5. Necrotizing Periodontal Disease
  • 8.6. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Retail Pharmacies and Drug Stores*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospital Pharmacies
  • 9.4. Dental Clinics
  • 9.5. E-Commerce

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Kaken Pharmaceutical Co. Ltd.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Bausch Health
  • 12.3. Colgate-Palmolive
  • 12.4. Medicom
  • 12.5. Pfizer Inc.
  • 12.6. 3M
  • 12.7. Den-Mat Holdings, LLC
  • 12.8. Dentsply Sirona
  • 12.9. Xttrium Laboratories, Inc.
  • 12.10. Dexcel Pharma

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us